Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New antimitotic agent described by Czech investigators

March 10, 1998

Nitrullin evaluated in phase II for melanoma

March 10, 1998

Janssen describes a new cell migration inhibitor

March 10, 1998

DepoCyt FDA review period extended in order to review additional patient data

March 9, 1998

Anticancer imidazoles from Merck & Co.

March 9, 1998

Evidence of clinical efficacy of ukrain in colorectal cancer

March 9, 1998

Overview of preclinical and clinical evaluation of Russian nitrosourea

March 9, 1998

S-1 demonstrates excellent antitumor activity in phase II

March 9, 1998

Lilly antifolate evaluated in phase II

March 9, 1998

Favorable phase I results obtained with G-3139 in NHL

March 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...